You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昂利康(002940.SZ):擬1.57億元增持科瑞生物(832780.OC)15.74%股份
格隆匯 02-18 17:45

格隆匯2月18日丨昂利康(002940.SZ)公佈,基於對科瑞生物(832780.OC)發展潛力的充分認可,公司擬以自有或自籌資金約1.57億元人民幣通過協議方式受讓海南盛健持有的科瑞生物15.74%股份,共計約1125.64萬股。

在該次交易前,根據公司總經理辦公會會議決議,公司已通過全國中小企業股份轉讓系統交易平台以自有資金2907.58萬元累計購買了科瑞生物2.91%股份,計約207.82萬股;該次交易完成後,公司將合計持有科瑞生物18.65%股份,合計約1333.46萬股。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account